期刊文献+

选择性胆固醇吸收抑制剂临床应用中国专家共识(2011版) 被引量:5

原文传递
导出
摘要 为促进并规范降胆固醇药物的合理应用,2010年国内专家曾制定并颁布了“胆固醇吸收抑制剂临床应用中国专家共识”。该共识发布后在国内引起广泛关注,为增进广大临床医生对此类药物的认识起到了积极作用。随着国际上多项新的临床与基础研究结果发表,进一步阐明了降胆固醇药物的作用机制与疗效,在此背景下,中国老年学学会心脑血管病专业委员会与中国医师协会循证医学专业委员会再次组织国内相关领域专家,对这一共识性文件进行修订,旨在为选择性胆固醇吸收抑制剂的合理应用提供更为全面的信息。
出处 《中华内科杂志》 CAS CSCD 北大核心 2011年第11期985-989,共5页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献34

  • 1Boggs P T, Tolle J W. Sequential quadratic programming. Acta Numerica, 1995,41-51
  • 2Byrd R H, Marazzi M, Nocedal J. On the convergence of Newton iterations to non-stationary points. Math. Programming, 2004,99:127-148
  • 3Dennis J E Jr, El-Alem M, Maciel M C. A global convergence theory for general trust region based algorithms for equality constrained optimization. SIAM J.Optim, 1997,7:177-207
  • 4Dennis Jr J E, Schnable R B. Numerical methods for unconstrained optimization and nonlinear equations. Prentice-Hall, Englewood Cliffs, NJ 1983
  • 5Fletcher R. Practical methods of optimization. Volume 2, Constrained Optimization (John Wiley and Sons, New York and Toronto) 1981
  • 6Powell M J D. A hybrid method for nonlinear equations. in Numerical Methods for nonlinear Algebraic Equations, (ed. P. Rabinowitz),Gordon and Breach, London 1970
  • 7Powell M J D, Yuan Y. A recursive quadratic programming algorithm for equality constrained optimization. Math. Programming, 1986,35:265-278
  • 8Cohen JC, Pertsemlidis A, Fahmi S, et al. Multiple rare variants in NPCIL1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc Natl Acad Sci U S A, 2006, 103:1810-1815.
  • 9Chen CW, Hwang JJ, Tsai CT, et al. The g.-762T > C polymorphism of the NPC1LI gene is common in Chinese and contributes to a higher promoter activity and higher serum cholesterol levels. J Hum Genet, 2009,54:242-247.
  • 10Burnett JR, Huff MW. Cholesterol absorption inhibitors as a therapeutic option for hypercholesterolaemia. Expert Opin Investig Drugs ,2006,15 : 1337-1351.

共引文献1

同被引文献92

  • 1徐大立,陶以嘉,范永华,刘颖,沈德怀.心力衰竭研究进展[J].心血管病学进展,2004,25(B12):114-118. 被引量:9
  • 2徐大立,刘颖,范永华,王燎,陶以嘉.急性心肌梗死的研究进展[J].心血管病学进展,2005,26(B08):86-92. 被引量:9
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5232
  • 4The Collaborative Research Group for the Second Multi-center Survey of Clinical Management of Dyslipidemia in China.第二次中国临床血脂控制达标率及影响因素多中心协作研究[J].中华心血管病杂志,2007,35(5):420-427. 被引量:126
  • 5中华医学会心血管病学分会 中华心血管病杂志编辑委员会.急性sT段抬高型心肌梗死诊断和治疗指南.中华心血管病杂志,2010,:675-675.
  • 6Knopp RH. Drug treatment of lipid disorders [ J ]. N Engl J Med, 1999,341 (7) :498.
  • 7Stein E. Managing dyslipidemia in the high-risk patient [J]. Am J Cardiol ,2002 , 89 ( S A ) :50C.
  • 8Sudhop T, Ltitjohann D, Kodal A, et al. Inhibition of intestinal cholesterol absorption by ezetimj,be in humans [ J]. Circulation ,2002,106( 15 ) : 1943.
  • 9Clarenbach JJ, Reber M, Ltitjohann D, et al. The lipidlowering effect of ezetimibe in pure vegetarians [ J ]. J Lipid Res, 2006,47 ( 12 ) : 2820.
  • 10van Heek M, Farley C, Compton DS, et al. Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function[J]. Br J Pharmacol,2001,134( 2 ) :409.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部